Abstract
The emergence of multidrug-resistant tuberculosis strains and the coinfection with HIV, together with advances in immunology, have led to renewed interest regarding ways to exploit the immune responses against Mycobacterium tuberculosis therapeutically. Here we review the fundamentals of tuberculosis therapy in view of the epidemiological and clinical challenges, and explore the experience with immune-based therapies for the treatment of active tuberculosis. These immune-based therapies are discussed here with the aim of assessing their potential use as adjuncts to chemotherapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 461-474 |
| Number of pages | 14 |
| Journal | Expert Review of Anti-Infective Therapy |
| Volume | 5 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antibodies
- Cytokines
- Immunotherapy
- Tuberculosis
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
- Virology
- Microbiology
Fingerprint
Dive into the research topics of 'Immunological options for the treatment of tuberculosis: Evaluation of novel therapeutic approaches'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS